Patents by Inventor Elisabeth Bjork

Elisabeth Bjork has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240105289
    Abstract: The present disclosure relates to a system and method for use in performing clinical endpoint adjudication to provide: efficient, automated clinical event classification and medical review triage; reduce the time to identify clinical events; a unified, consistent process for classification of clinical events; and proactive identification of events in near real-time.
    Type: Application
    Filed: January 25, 2022
    Publication date: March 28, 2024
    Inventors: FAISAL KHAN, ELISABETH BJORK, TOMAS ANDERSON, ANDERS PERSSON, CRISTINA DURAN, GLYNN DENNIS, SHAMEER KHADER, EMMETTE HUTCHISON, HALSEY LEA, SREENATH NAMPALLY, MALIN WALLANDER, ANDREAS JAREMO
  • Publication number: 20020193368
    Abstract: The present invention relates to the use of potassium channel agonists for the treatment of insulitis associated with various forms of diabetes such as IDDM, NIDDM, SPIDDM (LADA) and gestational diabetes.
    Type: Application
    Filed: August 6, 2002
    Publication date: December 19, 2002
    Inventors: John Bondo Hansen, Anders Karlsson, Mikael Kullin, Stellan Sandler, Elisabeth Bjork, Zhanchun Li, Birgitte Michelsen, Jesper Svendstorp Lund
  • Publication number: 20020032193
    Abstract: The present invention relates to the use of potassium channel agonists for the treatment of insulitis associated with various forms of diabetes such as IDDM, NIDDM, SPIDDM (LADA) and gestational diabetes.
    Type: Application
    Filed: June 26, 2001
    Publication date: March 14, 2002
    Inventors: John Bondo Hansen, Anders Karlsson, Mikael Kullin, Stellan Sandler, Elisabeth Bjork, Zhanchun Li, Birgitte Michelsen, Jesper Svendstorp Lund